MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Aerie Pharmaceuticals Company Profile (NASDAQ:AERI)

Consensus Ratings for Aerie Pharmaceuticals (NASDAQ:AERI) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $30.00 (81.82% upside)

Analysts' Ratings History for Aerie Pharmaceuticals (NASDAQ:AERI)
Show:
DateFirmActionRatingPrice TargetActions
8/6/2015Cantor FitzgeraldReiterated RatingBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Canaccord GenuityReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Brean CapitalReiterated RatingBuy$33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/17/2015Brean CapitalBoost Price TargetBuy$24.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015Canaccord GenuityUpgradeHold -> Buy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015Cantor FitzgeraldBoost Price TargetBuy$15.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015RBC CapitalBoost Price TargetOutperform$27.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015Needham & Company LLCUpgradeHold -> Buy$13.27 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Piper JaffrayReiterated RatingBuy$7.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015Brean CapitalReiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015Canaccord GenuitySet Price TargetHold$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Cantor FitzgeraldUpgradeHold -> Buy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Stifel NicolausLower Price TargetBuy$40.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015RBC CapitalLower Price TargetOutperform$50.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Canaccord GenuityDowngradeBuy -> Hold$40.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Cantor FitzgeraldDowngradeBuy -> Hold$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Brean CapitalLower Price TargetBuy$46.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015RBC CapitalBoost Price TargetOutperform$45.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015Cantor FitzgeraldReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015MLV & Co.Reiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015Brean CapitalInitiated CoverageBuy$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2015Canaccord GenuityReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015MLV & Co.Reiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Cantor FitzgeraldInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/17/2014RBC CapitalBoost Price TargetOutperform$36.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/3/2014Canaccord GenuityInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2014RBC CapitalBoost Price TargetOutperform$27.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2014Needham & Company LLCBoost Price TargetBuy$26.00 -> $37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2014RBC CapitalLower Price TargetOutperform$28.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014Stifel NicolausBoost Price TargetPositive -> Buy$22.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014RBC CapitalBoost Price TargetOutperform$25.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014Needham & Company LLCBoost Price TargetBuy$22.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2013Needham & Company LLCInitiated CoverageBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2013Canaccord GenuityInitiated CoverageBuy -> Buy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2013RBC CapitalInitiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2013Stifel NicolausInitiated CoverageBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/28/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha